In exercise, as well as cancer and ischemia, hypoxia-inducible factor 1 (HIF1) transcriptionally activates hundreds of genes vital for cell homeostasis and angiogenesis. While potentially beneficial in ischemia, upregulation of the HIF1 transcription factor has been linked to inflammation, poor prognosis in many cancers, and decreased susceptibility of tumors to radiotherapy and chemotherapy. Considering HIF1's function, HIF1␣ protein and its hydroxylation cofactors look increasingly attractive as therapeutic targets. Independently, antioxidants have shown promise in lowering the risk of some cancers and improving neurological and cardiac function following ischemia. The mechanism of how different antioxidants and reactive oxygen species influence HIF1␣ expression has drawn interest and intense debate. Here we present an experimentally based computational model of HIF1␣ protein degradation that represents how reactive oxygen species and antioxidants likely affect the HIF1 pathway differentially in cancer and ischemia. We use the model to demonstrate effects on HIF1␣ expression from combined doses of five potential therapeutically targeted compounds (iron, ascorbate, hydrogen peroxide, 2-oxoglutarate, and succinate) influenced by cellular oxidation-reduction and involved in HIF1␣ hydroxylation. Results justify the hypothesis that reactive oxygen species work by two opposite ways on the HIF1 system. We also show how tumor cells and cells under ischemic conditions would differentially respond to reactive oxygen species via changes to HIF1␣ expression over the course of hours to days, dependent on extracellular hydrogen peroxide levels and largely independent of initial intracellular levels, during hypoxia.
The transcription factor hypoxia-inducible factor (HIF) plays a critical role in the mammalian response to oxygen (O 2 ) levels. HIF1, the first characterized member of the HIF family, transcriptionally activates hundreds of genes associated with angiogenesis in cancer, exercise, and ischemia, as well as energy metabolism, nutrient transport, cell cycle, and cell migration (85, 98) .
HIF1␣ and HIF1␤ make up the HIF1 heterodimer. The ␤-subunit is constitutively expressed in cells. Expression of the ␣-subunit may be induced by a number of pathways, and its degradation is highly sensitive to O 2 levels. Called a master switch for hypoxic gene expression (76, 85) , intracellular HIF1␣ in normoxia is experimentally undetectable; during hypoxia, it rapidly accumulates in the cell nucleus and triggers gene expression. Molecular players involved in this process have come to light over the past 6 years; research has begun to define roles for prolyl hydroxylases, iron, ascorbate, hydrogen peroxide, 2-oxoglutarate, succinate, and von Hippel-Lindau protein in the HIF1 pathway.
Concomitantly, the study of reactive oxygen species (ROS) and the interest in antioxidants as potential dietary supplements for prevention of cancer, cardiac dysfunction, and neurodegeneration has grown rapidly. Ongoing debate surrounds the role of these compounds in hypoxic responses and the utility in pursuing them as preventative therapeutics. Some studies have shown increased ROS expression in hypoxia (10, 40) , while others show a decrease (33, 96) . Increased HIF1␣ expression has been found to contribute to mitochondrial activity (1) , and specifically ROS formation, during hypoxia (26, 40, 81) . However, other studies have demonstrated a decrease in HIF1␣ with increasing ROS (22, 99) . Finally, some studies have shown no effects of H 2 O 2 (87) or mitochondrial ROS in general (96) . Related observations seem nearly as conflicting. Under hypoxic conditions, mitochondrial complex III may produce ROS, and the presence of high ROS concentrations generated from the mitochondria has been shown to stabilize HIF1␣ (8, 9, 20, 26) . On the other hand, ROS may be produced in the cytosol, derived from NADPH oxidases (17, 33) , and ROS may play a larger role in HIF1␣ expression during normoxia than hypoxia (43) .
There are several hypotheses as to how ROS interact with the HIF1 pathway and alter HIF1␣ expression (recent related reviews include references 41 and 75) . One possibility is that hydrogen peroxide oxidizes ferrous iron (Fe 2ϩ ) to its ferric form (Fe 3ϩ ), prohibiting the necessary binding of ferrous iron to the HIF1␣ hydroxylation enzymes, prolyl hydroxylases (PHDs) (71) . Another change could be in the recruitment of ascorbate as a free radical scavenger, preventing ascorbate from reducing ferric iron and/or preventing ascorbate from binding directly to the PHDs. If ROS increased rather than decreased free Fe 2ϩ , as suggested by some experiments, HIF1␣ hydroxylation would instead increase (56) . Additionally, 2-oxoglutarate (2OG) and succinate (SC) are also compounds involved in HIF1␣ hydroxylation whose concentrations could be altered by free radicals and mitochondrial dysfunction (38, 56, 71) . A fourth mechanism by which ROS could influ-ence the HIF1 pathway is through changing the availability of oxygen to bind directly to the PHDs or changing PHD phosphorylation.
To address these alternate mechanisms and analyze possible competing factors involved in pro-and antioxidant therapy in cancer and ischemia, we developed a computational model describing the in vivo system and used it to observe dynamics currently inaccessible at the molecular level in vivo. Experimentally, ROS have been shown to affect the HIF1 pathway through changes in H 2 O 2 , Fe 2ϩ , Asc, 2OG, or SC levels (61, 71) , and mechanisms involving these compounds were the focus of this study.
The model consists of kinetic equations mapping the molecular steps in HIF1␣ degradation in normoxia, HIF1␣ synthesis in chronic hypoxia, and effects of the enzyme and cofactors involved in the HIF hydroxylation pathway. Kinetic values were estimated from in vitro studies, and results were validated by comparison to a series of independent experimental data. The input is cellular oxygen level, and the output is HIF1␣ levels in the nucleus in relation to necessary intermediate reactions, including reactions with prolyl hydroxlylase, iron, 2-oxoglutarate, ascorbate, succinate, and von Hippel-Lindau (VHL) ligase. The model was expanded to represent two possible mechanisms of how ROS interact in the HIF1 pathway: (i) at high concentrations, ROS induce HIF1␣ by decreasing the activity of prolyl hydroxylases, and ROS effects can be silenced by antioxidants; (ii) in some cells with damaged mitochondria, the opposite effect (ROS decreasing HIF1 activity) is possible through increased iron and 2-oxoglutarate, cofactors in HIF1␣ degradation.
Using this model, we demonstrate how ascorbate, iron, hydrogen peroxide, 2-oxoglutarate, and succinate would alter HIF1␣ expression in two representative hypoxic microenvironments: cancer cells and cells during ischemia. We show how these compounds affect adaptation to chronic hypoxia, taking into account possible changes in succinate and reactive oxygen species levels associated with increased anaerobic metabolism and oxidative phosphorylation, such as those found in cancer. Results offer insight into the pro-and antioxidant effects of five compounds present in the HIF1 pathway and how they differ in a tumor microenviroment compared to ischemia. The model demonstrates temporal-specific molecular mechanisms that could be harnessed for use in cancer prevention, recovery from ischemic injury, and repression of angiogenesis and inflammatory signaling regulated by HIF1␣ expression.
MATERIALS AND METHODS
Formulation of the computational model. A model of oxygen sensing by HIF1␣ was introduced and validated elsewhere (77) . Here, we built an HIF1 computational model to incorporate potential mechanisms of ROS and antioxidants reacting within the HIF1␣ pathway. We represented ROS through two distinct means: (i) changes in the cofactors involved in HIF1␣ hydroxylation and (ii) the addition of hydrogen peroxide. The first mechanism is through direct increases or decreases in the concentration (availability) of certain cofactors of the hydroxylation pathway, i.e., by altering [Fe 2ϩ ], [Asc] , and [2OG] levels, independent of H 2 O 2 concentrations. The second mechanism focuses on H 2 O 2 as a representative ROS and affects HIF1␣ hydroxylation through Fe 2ϩ and a Fenton reaction.
The complete model, based on an extensive analysis of experimental data, includes the hydroxylation of HIF1␣ by PHDs and the ubiquitination of hydroxylated HIF1␣ by VHL. Table 1 lists the compounds relevant to the current model. Equation 1 describes the overall scheme of HIF1␣ degradation. Equations 2 and 3 depict the oxidation of iron by reaction with hydrogen peroxide and the reduction of iron by ascorbate, respectively. The complete model includes HIF1␣ hydroxylation, independent reactions of iron and ascorbate, hydrogen peroxide production, succinate accumulation and product inhibition, PHD2 synthesis and HIF1␣ synthesis in chronic hypoxia, and the binding of HIF1␣ to VHL.
The scheme of the overall biochemical reaction of HIF1␣ hydroxylation, with succinate product inhibition is as follows:
HIF1α
HIF1α hydroxylated (1) Iron oxidation by reaction with hydrogen peroxide is depicted as follows:
Iron reduction by ascorbate (2, 101) is depicted as follows:
Enzyme-substrate binding kinetics are used to describe the hydroxylation reactions. Governing equations are determined from mass balances for the substrate and the intermediate enzyme-substrate complexes. A combination of enzymesubstrate saturation assumptions was used for the binding of iron, ascorbate, 2-oxoglutarate, and oxygen to PHD2, PHD2 hydroxylation of HIF1␣, and VHLmediated ubiquitination. In the hydroxylation reaction of PHDs with HIF1␣, we represented the binding of PHD2 with the substrates iron, 2-oxoglutarate, and oxygen sequentially; the redox reactions for ascorbate and iron are included as separate equations (77) . These hydroxylation steps and their output were validated against experiments previously (77, 78) . Model inputs are initial compound concentrations, including cellular O 2 levels ( Table 2 ). The output is HIF1␣ levels in the cell cytoplasm. The described kinetic model includes all previously studied reactions (77, 78) . Three feedback loops, HIF1 autocrine upregulation, HIF1 induction of PHD2, and succinate product inhibition, were determined to govern HIF1 levels and regulate the response to chronic hypoxia ( Fig. 1) (78) . Production terms were included for the synthesis of HIF1␣ and PHD2 at 3 and 4 h of hypoxia, respectively. The PHD2/HIF1␣ synthesis ratio is 0.01:0.05 in all cases presented in this paper; this ratio was chosen by estimating that between 4 and 8 hours there is a sixfold increase in HIF1␣ compared to initial conditions. C 1 , a constant in the synthesis terms for PHD2 and HIF1␣, was set at 0.1 (78) .
The effects of succinate were represented by one of two mechanisms, as previously described (78) . Briefly, product inhibition by succinate was included by modifying the backward kinetic rates for the PHD2 complex binding to unhydroxylated HIF1␣. This inhibition could result from 2-oxoglutarate being converted into a succinic acid salt or succinate and therefore not allowing 2OG to be available to the PHD2 forward hydroxylation reaction. As an alternate possibility, succinate accumulation could trigger a change in PHD2 activity or HIF1␣ levels independent of product inhibition, through a yet-unknown signaling mechanism. A hypothesis is that succinate accumulation and related tricar- (45, 104) that leave this as a possibility to explore. One way of modeling this potential change is by altering the oxygen available for hydroxylation as a function of succinate production. In the figures shown below, we refer to the two mechanisms as "production inhibition" and "SC signals O 2 depletion." In the present study, the model was expanded to include the production, transport, and metabolism of hydrogen peroxide, a representative ROS that is overproduced by mitochondria malfunction and during ischemic stress (Fig. 1) .
Here we only present equations not included in our previous work.
Hydrogen peroxide. Hydrogen peroxide is a reactive oxygen species that is also involved in the oxidation of Fe 2ϩ , a cofactor in HIF1␣ hydroxylation (equation 3). Changes in the concentration of hydrogen peroxide were incorporated into the model by a mass balance to represent H 2 O 2 production (either release from the cell mitochondria during hypoxia or NADPH oxidase-dependent H 2 O 2 production), H 2 O 2 degradation by glutathione peroxidase and catalase, and influx from the surrounding extracellular environment. H 2 O 2 degradation and production were represented in all cell types through additional kinetic terms. The kinetic equation for hydrogen peroxide production and degradation is as follows:
where p is a constant production term, estimated from experimental data in different microenvironments. (59) . See text for further details. k total refers to the total H 2 O 2 intracellular consumption in intact cells and was also taken from experiments. t is time, in minutes. The maximum value was used where there was a range, except for ͓H 2 O 2 ͔ 0 for normal cells, which was set as 0.02 M.
b H 2 O 2 production rates measured for in vitro rat liver cell and subcellular extracts using a cytochrome c peroxidase assay (18); the 0.45 mol/min upper value refers to the initial rate found in cell homogenates, while the lower limit is estimated from adding up the H 2 O 2 production from all measured subcellular compartments.
c The minimal value for the pseudo-first-order kinetic term of 0 min Ϫ1 was estimated from experiments showing minimal concentrations of catalase in tumor cells (19) .
FIG. 1. Schematic of the HIF1␣ system during chronic hypoxia. Three feedback loops govern HIF1␣ hydroxylation: HIF1␣ synthesis (dashed line), PHD2 synthesis (light gray line), and succinate production inhibition (dark gray line). Succinate is also a metabolic product of the TCA cycle and is overproduced in some cancers. Two hypothesized, opposite effects of reactive oxygen species on HIF1␣ expression are shown: increasing HIF1␣ expression by blocking PHDs and decreasing HIF1␣ levels by signaling an increase in PHD activity and hydroxylation. (12, 62) . Table S1 in the supplemental material shows relative catalase and GPx activities for a number of cancer cell types, compared to noncancerous tissue. These values lend additional weight to the assumption that there is a threefold difference in catalase activity between tumor and noncancerous conditions (59) .
To complete the representation of H 2 O 2 intracellular concentration, possible diffusion of H 2 O 2 into and out of the cell needs to be addressed. The H 2 O 2 mass balance including transport is as follows: (37) and estimated to be lower than 20 nM in the absence of exogenous sources in another study (82 Table 5 , below, for specific tumor types.
Numerical solution. The system of nonlinear differential equations was solved using Mathworks Matlab software. The ode23s solver, based on a modified Rosenbrock formula, was used to find a solution for the series of 19 differential equations. For the time integration, the solver used adjustable time steps with a default absolute error tolerance in the solution of 10 Ϫ6 M.
RESULTS
Tumor microenvironment. The tumor microenvironment is predominantly associated with hypoxia, high rates of glycolysis, and high levels of reactive oxygen species. Furthermore, select enzymes that degrade ROS (e.g., catalase for H 2 O 2 ) appear in lower levels in tumor-bearing mammals than in healthy ones (19, 25) . Results of the model show effects of ROS on the HIF1␣ pathway in tumors through two proposed mechanisms: (i) direct changes in concentrations of the hydroxylation cofactors Fe 2ϩ , Asc, and 2OG, or (ii) introduction of elevated levels of H 2 O 2 and changes in H 2 O 2 metabolism, production, and transport.
ROS in tumors represented through Fe 2؉ , Asc, and 2OG. Experiments suggest that ROS interact with the HIF1␣ pathway by altering the availability of Fe 2ϩ and Asc, hydroxylation cofactors (22, 34, 38, 54) . The model showed effects of high ROS levels on a hypothetical microenvironment by changes in Fe 2ϩ and Asc levels ( and Asc, the model predicted a maximum in unhydroxylated HIF1␣ concentration near 4.5 h, whereas when ROS were represented by a decrease in [Fe 2ϩ ] 0 and [Asc] 0 , the time to maximum HIF1␣ expression shifted by several hours, and HIF1␣ remained elevated over several days ( Fig. 2A) . Tenfold c Reperfusion is modeled with hypoxia ( Fig. 6 and 7 ) and normoxia (see Fig. S3A and B in the supplemental material).
decreases in [Fe 2ϩ ] 0 and [Asc] 0 led to an approximately fivefold increase in maximum HIF1␣ expression ( Fig. 2A) .
Other experiments indicate that Fe 2ϩ and 2-oxoglutarate are released by damaged mitochondria. 2-Oxoglutarate, like succinate, is a product of the citric acid cycle. In hypoxia, it has been hypothesized that nitric oxide causes mitochondrial dysfunction and thereby 2OG and Fe 2ϩ upregulation mediated by the reactive oxygen species peroxynitrite (56) . Increased intracellular 2OG and Fe 2ϩ then contribute to increased hydroxylation of HIF1␣ by the PHDs. The model showed effects of high ROS levels on a hypothetical microenvironment by changes in Fe 2ϩ and 2OG levels (Fig. 2B) . ROS in tumors with succinate effects. Certain tumors, such as pheochromocytomas and paragangliomas, are associated with mitochondrial mutations and deficiencies in the enzyme succinate dehydrogenase (SDH). Succinate and 2-oxoglutarate are also intermediate products in the citric acid (TCA) cycle.
In the hydroxylation reaction, PHD2 simultaneously splits oxygen to hydroxylate HIF1␣ and oxidizes and decarboxylates 2-oxoglutarate to succinate (83) . Downregulation of SDH, an enzyme that degrades succinate to fumarate, leads to intracellular succinate accumulation, HIF1␣ stabilization, and HIF activation (83) . Through in vitro and in vivo experimental observations, succinate was hypothesized to act as a product inhibitor of the PHD hydroxylation reaction of HIF1␣ (55, 74, 78, 83) . Deciphering the relationship between succinate and ROS has been the subject of numerous studies, as well. Because of the structure of SDH redox centers, mutations in SDH have been predicted to result in ROS formation (104) . Studies using both Caenorhabditis elegans (48, 86) and tumors with SDH mutations (49) have shown increased ROS. However, other studies have provided evidence that ROS is not necessary for succinate accumulation to produce a pseudo-hypoxic effect and stabilization of HIF1␣ (64, 74, 84) . Shedding light on (42) . Another relevant study showed that SDH mutations could specifically contribute to tumor formation via both ROS production and a proliferative response associated with succinate accumulation (91) . The computational model's predicted effect of ROS on tumors with SDH deficiency is shown in Fig. 2C ; Table 4 shows the initial concentrations used to represent conditions found in vivo (78) . ROS, represented by a 10-fold decrease in initial Fe 2ϩ and 2OG concentrations, shifted the time to the peak accumulation of HIF1␣ by several hours (Fig. 2B) . The time to peak HIF1␣ accumulation was shifted up to ϳ48 h, when the model was used to represent in vitro conditions of succinate product inhibition (see Fig. S1B and C in the supplemental material; in these figures, [SC] 0 is 500 M, the maximal concentration used to represent SDH deficiency in published in vitro experiments) (83) . ROS, represented by a 10-fold decrease in initial Fe 2ϩ and Asc, also shifted the time to peak accumulation of HIF1␣ (see Fig. S1D in the supplemental material).
ROS in tumors represented through H 2 O 2.
The effect of ROS on HIF1␣ could be solely related to one ROS species, H 2 O 2 , its initial concentration, and its production in tumor cells (61) . Measurements of H 2 O 2 in vivo are difficult to obtain, and estimates for a base value of 0.2 M in tumors were obtained from experiments, as described above. Fibroblasts that became tumorigenic with the expression of Nox1, the catalytic subunit of an NADPH oxidase, expressed H 2 O 2 at a level 10-fold that of normal fibroblasts (6) , in agreement with a number of studies that had established the relationship between increased H 2 O 2 and tumorigenicity (24, 30, 90) . Results from the model show the effect of an increase in initial [H 2 O 2 ] 0 , H 2 O 2 production, and H 2 O 2 metabolism predicted for a tumor cell (Fig. 3 and 4) and? a tumor cell with SDH deficiency represented by two distinct mechanisms ( Fig. 4 ; see also Fig. S2 in the supplemental material) . Additionally, the effects of extracellular H 2 O 2 on HIF1␣ are predicted and compared to available in vitro experimental data (see Fig. S4 in the supplemental material).
Ischemia microenvironment. The ischemic microenvironment is associated with hypoxia, and high levels of reactive Table 2 . oxygen species are found both following the ischemic insult and during reperfusion.
ROS in ischemia represented through H 2 O 2.
The mechanism of ROS involvement in HIF1␣ expression during ischemia could be solely related to H 2 O 2 initial concentrations and production. If this is the case, the model predicts a temporal expression of HIF1␣ in cells exposed to ischemia, similar to that of tumor cells (Fig. 3) . This expression changes at the onset of reperfusion, which induces a larger amount of H 2 O 2 production and alters H 2 O 2 transport ( Fig. 5 ; see also Fig. S4 in the supplemental material). If H 2 O 2 extracellular levels remain elevated, the resulting increase in HIF1␣ lasts, uninhibited by any mechanism currently modeled, whether the intracellular conditions are approximated as hypoxia or normoxia (see Fig. S4 in the supplemental material) . (Fig. 6) . In comparison to the Fe 2ϩ and Asc mechanism of ROS effects (a 10-fold increase in Fe 2ϩ and Asc) (Fig. 6A) , an increase in 2OG accelerates the production of HIF1␣ and elevates its expression much higher by 8 h of hypoxia (Fig. 6B) .
ROS in ischemia represented

DISCUSSION
The variable effects of ROS on HIF1␣ can be attributed to three main factors: (i) the degree of hypoxia, (ii) the form and intracellular location of ROS produced, and (iii) the molecular microenvironment of the cell. The third was the focus of this model. Before discussing the relevance of the microenvironment, it is worthwhile to briefly describe the roles of the first two factors, as they relate to the presented results.
ROS, O 2 levels, and ROS species. ROS production requires oxygen, so it is not surprising that ROS are expressed in different concentrations during anoxia, hypoxia, and normoxia. However, a direct correlation between ROS levels and O 2 availability remains elusive. Low O 2 limits formation of superoxide and its by-products (33), while hypoxia also has been shown to increase ROS, possibly through release by the mitochondria electron transport chain (41) . Equally intriguing, ROS appear to play distinctly different roles in anoxia, hypoxia, and normoxia, with respect to the HIF1 system. In anoxia, the (22, 54) . In related experiments, during normoxia, high ROS levels increased HIF1␣, by blocking PHD hydroxylation. Additional studies have also indicated that in long-term hypoxia (12 h), the effect of ROS is to signal HIF1␣ degradation and downregulate HIF1␣ expression (27) . In contrast, other experiments have shown in hypoxia that ROS upregulated HIF1␣ (6, 40, 75) . One explanation for the conflicting effects of ROS on HIF1␣ may be that HIF1␣ expression is dependent on particular reactive oxygen species, and not others (20) ; experiments differ in how they have measured ROS and in what cell types. ROS is produced by several means, which will affect ROS location and signaling. In normal cells, mitochondrial complex I and III and cytosolic monoamine and NADPH oxidases produce H 2 O 2 . In cancer cells, ROS, and H 2 O 2 in particular, are additionally overproduced by mitochondrial respiration, while in ischemia, cells may be susceptible to ROS from both mitochondrial dysfunction and the extracellular environment, including effects of reperfusion injury. In both cases, inflammatory cells may also release ROS locally and affect intracellular levels in tumors and ischemic cells. Of all reactive oxygen species, H 2 O 2 seems to be the one with the noticeable effect on the HIF1 system (20, 34, 61) . However, the reactive oxygen species peroxynitrite may serve as an oxygen donor during HIF1␣ hydroxylation, as well as mediate Fe 2ϩ and 2OG release from the mitochondria (56, 89) , and effects of superoxide on HIF1␣ have been shown in renal carcinoma (46) and renal medullary interstitial cells (103) .
Predictions: ROS and the cellular microenvironment. The molecular environment, the focus of this work, distinguishes why the effects of ROS differ between tumor cells and ischemic cells. In tumor cells, the duration of hypoxia is generally longer, and the cell adapts to anaerobic metabolism and likely relatively stable levels of ROS production. HIF1␣ levels peak, as in normal cells, before 12 h (Fig. 4) , and do not become elevated again until several days (see Fig. S3A in the supplemental material). In contrast, for the ischemic cell, the duration of ischemia is often hours or less, and cell is starved of oxygen but unable to adapt as readily as a cancer cell; additionally, the levels of ROS rapidly increase following the infarct or occlusion, and with perfusion, and then remain elevated for days, eventually decreasing ( Fig. 5 ; see also Fig. S4A and B in the supplemental material).
ROS mechanisms. We represented the effects of ROS on the HIF1␣ through two different mechanisms: (i) altering the relative concentrations of cofactors in PHD2 hydroxylation of HIF1␣ and (ii) H 2 O 2 production, transport, and metabolism. Both mechanisms involve the availability of free ferrous iron (Fe 2ϩ ), a cofactor in the hydroxylation reaction, via a mechanism that has been shown in experiments (34) . They differ in that the first mechanism was modeled by changing the availability of Fe 2ϩ and Asc ( Fig. 2A and 6A) or Fe 2ϩ and 2OG
( Fig. 2B and C and 6B), while H 2 O 2 only altered the availability of free ferrous iron in the model. Changes in H 2 O 2 concentration were highly dependent on the microenvironment (Tables 2 and 3 ).
The results from the model lend credence to the hypothesis that ROS interacts with the HIF1 system through several different mechanisms, and they may help explain conflicting experiments on HIF1␣ expression and ROS (Table 5 ). If ROS work by both increasing Fe 2ϩ and Asc or 2OG (Fig. 2 and 6 ) and increasing H 2 O 2 (thereby decreasing free Fe 2ϩ ) (Fig. 3, 4 , and 5), depending on the hypoxic conditions, then there could be a dual effect of ROS so that in some cases it upregulates HIF1␣ and in others it downregulates it. Moreover, in the first mechanism, Fe 2ϩ , Asc, and 2OG are quickly depleted in ischemic-reperfusion conditions, and the relatively lower HIF1␣ level is a transient effect (Fig. 6) . Beyond 5 to 12 h (with a 10-fold increase in 2OG and Asc, respectively), HIF1␣ levels reach the same level or higher, as they do using H 2 O 2 alone to represent ROS ( Fig. 6 ; see also Fig. S4B and C in the supplemental material). Depending on the duration of hypoxia in experiments, the model then predicts the same ROS conditions would yield either a relative upregulation or downregulation of HIF1␣. Model results using H 2 O 2 as the representative ROS are in agreement with experimental studies showing H 2 O 2 depletes ascorbate (70) (data not shown). The effect of an infinite source of Asc and free Fe 2ϩ has not yet been measured experimentally or modeled with respect to the HIF1␣ system and ROS; this would be an interesting test of altering hypoxic response through nutritional supplementation.
ROS in cancer and in ischemia. (i) H 2 O 2 in cancer.
Restricting the effect of the ROS in the model to changes in H 2 O 2 levels offers insight into how differences in cancer and ischemic microenvironments determine distinct cell fates. The effects of H 2 O 2 on the HIF1␣ concentrations are dependent on the dose of H 2 O 2 , levels of hypoxia, and cell type. Seemingly contradictory, high levels of H 2 O 2 are associated not only with the progression of cancer to metastasis but also the susceptibility of cancer cells to cell death (61) . An existing hypothesis to explain this observation is that all cells, cancer cells included, have an upper threshold for H 2 O 2 concentration, above which apoptosis occurs and below which cells proliferate at a rate proportional to the amount of H 2 O 2 (36, 59) (Fig. 7) . The model predicts cancer cells reach a lower steady-state level of H 2 O 2 than cells exposed to ischemia and reperfusion (Fig. 8) . Assuming the threshold hypothesis is true, the model implies cancer cells are more apt to survive in their hypoxic microenvironment well beyond the survival time of cells exposed to ischemia-reperfusion, at the same duration of hypoxia.
Additionally, HIF1␣ expression is increasing as H 2 O 2 increases or remains elevated below the threshold (Fig. 7) , making the cancer cells more virile and less susceptible to radiation and chemotherapy (50) . Increased HIF1␣ expression triggers the production of angiogenic factors in both cancer and ischemic cells, but the ischemic cells have less of a chance to survive their high intracellular ROS levels, while angiogenesis fuels the cancer cells' proliferation. If ROS works through an increased Fe 2ϩ , Asc, or 2OG mechanism too, the time to peak HIF1␣ levels is delayed ( Fig. 2 and 6 ; see also giogenesis. Furthermore, there may be a threshold for maximum HIF1␣ levels like that hypothesized for H 2 O 2 levels, above which apoptosis occurs, in which case, again the cells exposed to ischemia-reperfusion would be more susceptible than cancer cells (Fig. 7B) concentration as a function of production, transport, and metabolism. The intracellular concentration of H 2 O 2 (high or low) rapidly reaches an equilibrium level dependent on extracellular concentrations. This is a function of its quick transport across the cell membrane (5, 16) , combined with the driving force of intracellular metabolism (see Fig. S2B and S3D in the supplemental material). As a consequence of the rapid equilibrium, initial concentrations of H 2 O 2 are of minimal relevancy, and the model predicts that sustained intermediate levels of intracellular H 2 O 2 have the most significant effect on increasing HIF1␣ expression in tumors and ischemia and altering the hypoxic response long term (Fig. 7A) (7) .
The model predicts reperfusion produces a far greater increase in H 2 O 2 -dependent HIF1␣ expression than ischemia alone (Fig. 5) , even while H 2 O 2 production decreases to normal levels with reperfusion after 3.5 h ( Table 2 ). This is true even if reperfusion is considered to provide enough oxygen for cells to reach normoxia (see Fig. S3A and B in the supplemental material). Anticipated high extracellular levels of H 2 O 2 during reperfusion drive this elevated H 2 O 2 -dependent HIF1␣ (Table 3) .
The model then highlights how regulating hydrogen peroxide temporally is essential in treatments for ischemia-reperfusion injury. In vivo, high oxidant stress following ischemia may drive angiogenesis, allowing recovery of normoxia through the growth of vessels, while on the other hand too high levels of oxidants damage tissues. Modeling is key to correctly pinpointing the effective time frame for therapeutics, and as the computational modeling advances with new experimental and clinical measurements, antioxidant and proangiogenic treatments could be tailored to individuals.
Metabolism of ROS: catalase, GPx, and variability. In experiments using human hepatoma cells, catalase overexpression did not show an appreciably different effect on HIF1 expression or transcriptional activity (87) . The opposite has been shown in other cell types (20) . The authors of the first study suggested that H 2 O 2 played little or no role as a signaling molecule in the hypoxic response. As another possibility, which could explain discrepancies between studies, H 2 O 2 may play a role in HIF1 activation only or predominantly in hypoxia, but not anoxia (81) . Our model suggests a third explanation. An increase in intracellular catalase concentration does not have a strong effect on the hypoxic response via direct HIF1 activation, while extracellular H 2 O 2 and catalase levels do. Lending support to the model's finding that extracellular H 2 O 2 greatly determines the cellular hypoxic response, recent studies have indicated catalase added to cell medium has a strong effect on cell-cell communication in microglia via NO signaling (47) . Furthermore, another study showed that an adenovirus containing catalase affected the activity of apoptosis signal-regulating kinase 1, another signaling molecule involved in hypoxia and ischemia, whose activity is dependent on H 2 O 2 and indirectly related to HIF1 (57) .
The model offers plausible mechanisms to explain several phenomena associated with ROS effects on the HIF1 system; however, it is worthwhile to mention limitations of the current model. In vivo intracellular H 2 O 2 concentrations depend on a number of parameters that vary by cell type. These parameters include the concentration and activities of the peroxisome enzyme catalase and glutathione peroxidase, predominant in the cell cytosol; both enzymes degrade H 2 O 2 into water. The concentrations and activities of these enzymes were approximated as constants in the model (Table 2) , and further studies would represent how known changes in their activities affect intracellular H 2 O 2 concentrations and the HIF1 system. For example, the concentration of catalase is known to vary with cell type, ranging from 4 ng/10 6 cells in lymphocytes to 850 ng/10 6 cells in macrophages (80) . The variability among endothelial cells is expected to be less; however, it has not been established experimentally to our knowledge (in bacteria, a variability in catalase activity of 10-to 20-fold has been assessed [79] ). Studies measuring tissue-level catalase activity lend weight to the model's assumption of constant catalase activity during ischemia and reperfusion (39) . However, the concentration and activity of intracellular catalase, as well as the scavenging enzyme GPx, are likely specific to the cell and tissue type, as well as age (67) (see Fig. S1 in the supplemental material). H 2 O 2 membrane transport has been modeled here as unlimited diffusion (65), while facilitated transport by aquaporins may also occur (15 The model predicts that in tumors, the metabolism of H 2 O 2 drives increased transport from the extracellular microenvironment, while H 2 O 2 production by a single cell is a fraction of what is being metabolized (see Fig. S3D in the supplemental material). The model approximated uniform metabolism and production throughout the cell, while production occurs in subcellular units or areas of the cytoplasm. As another consideration, the transport of H 2 O 2 into and out of the cell and intracellular membranes (i.e., peroxisomes) affects the H 2 O 2 gradients present in the cell. How the response to an isolated, high concentration of ROS differs from a cell's response to uniform intracellular ROS elevation merits exploration.
Another characteristic of the model suggests an avenue for experimental pursuit. The current model has no specific feedback on ROS effects. Model predictions for HIF1␣ accumulation in chronic conditions correlate well with a range of experiments showing a peak in HIF1␣ before 12 h ( Fig. 3 ; see also Fig. S2A in the supplemental material) . However, without a A systems view of HIF1␣ signaling. As HIF1 is a transcription factor, its protein regulation is interesting in the greater context of systems biology. From experiments and computational modeling thus far, in chronic hypoxia HIF1␣ has two positive autoregulatory feedback mechanisms, HIF1␣ upregulating itself and the hydroxylation product succinate downregulating PHD2 to upregulate HIF1␣, and one negative one, HIF1␣-dependent upregulation of PHD2 (78) . Furthermore, ROS regulates HIF1␣ expression; this provides another form of autocrine regulation by a hypoxic cell.
What does a hypoxic cell gain from these multiple regulatory pathways, both negatively and positively? Negative autoregulation alone speeds the response time for a closed regulatory circuit and leads to saturation in the protein. If HIF1␣ only regulated PHD2, and not itself, this would be the expected result; on the other hand, if HIF1␣ regulated HIF1␣ alone and not PHD2, the positive feedback would lead to a slower response time and could lead to indefinitely increasing HIF1␣ conditions. From experiments, HIF1␣ auto-upregulation occurs an hour or more prior to HIF1␣-dependent PHD2 upregulation. One might expect from this a characteristic peak found in HIF1␣ expression, with a chronic decay rate of HIF1␣ dependent on the synthesis ratio of PHD2:HIF1␣ (78). The staggered response coupling both positive and negative feedback then potentially optimizes both the degree of HIF1␣ upregulation and the speed of its regulation during periods of chronic hypoxia.
HIF1␣ protein regulation during hypoxic durations of less than 3 hours is modulated without feedback. This provides a response within minutes (HIF1␣ accumulation in hypoxia and HIF1␣ oxygen-dependent degradation). There is no need to keep the response on, once oxygen is restored. It may also be that some genes are upregulated by HIF1 specifically during long-term hypoxia, and the concentration or duration of the transient HIF1 response is insufficient to trigger their activation.
To summarize and weigh current hypotheses on ROS at a systems level, a brief network motif analysis of possible ROS mechanisms in regards to HIF1 and hypoxia is presented (Fig.  8) . Figure 8 provides circuit representations of hypotheses of ROS and HIF1␣ interactions. A coherent feed-forward loop refers to a circuit where the indirect path and the direct path yield the same response; an incoherent loop refers to one where the two paths cause opposite effects (3) . Of the three proposed mechanisms of ROS, the incoherent feed-forward type 1 (Fig. 8B) , is one of the most prevalent circuits in biological systems, albeit at the gene level (3) . In this case ROS may increase HIF1␣ through limiting O 2 availability, ferrous iron, and Asc or decrease HIF1␣ by increasing 2OG and Fe 2ϩ or donating O 2 in hypoxia, all cofactors in PHD2 hydroxylation. If ROS mechanisms can be described by this circuit, pulse-like dynamics in HIF1␣ expression may be possible; ROS would begin to upregulate HIF1␣ independently of PHD2 and then PHD2 would be upregulated by ROS, leading to HIF1␣ downregulation (3). Other possible mechanisms of ROS interactions are shown, as well as the effects of succinate and hypoxia globally on HIF1␣. At the transcriptional level, these configurations are rarer than the incoherent feed-forward type 1, and they are characterized by limited function.
If the prevalence of specific motifs at the transcriptional level can be extrapolated to molecular species and proteins, the presented circuit analysis helps support the hypothesis from the molecular model that ROS acts by both up-and downregulating HIF1, rather than one or the other. The allure of representing the system in circuit diagram form is both enhanced and tempered by the known biological complexity of the HIF1 system. In graphical form, hypothesized positive and negative controls on HIF1 become simplified; adding components, e.g., metabolic pathways, becomes relatively easy. However, even while highlighting characteristics of simple circuits and network motifs, the interactions, delay time, protein versus gene response, and multiple connections can alter the excepted benefits or characteristics of a particular motif.
The presented model demonstrates several molecular mechanisms for how ROS signaling can affect the HIF1 pathway through Fe 2ϩ , Asc, 2OG, SC, and H 2 O 2 . We showed how tumor cells and cells exposed to ischemia would differentially respond to ROS via changes to HIF1␣ expression over the course of hours to days. Model results also show that in hypoxia (both in cancer and ischemic microenvironments), H 2 O 2 intracellular levels rapidly reach equilibrium with extracellular levels, largely independent of initial intracellular levels. H 2 O 2 transport and metabolism, more than cellular production, dictate HIF1␣ levels. Antioxidants (e.g., Asc) can alter the amount of ROS that is metabolized intracellularly and restore free Fe 2ϩ levels, but unless the extracellular ROS levels change too, this effect is transient. Applied to therapeutic manipulation of hypoxic response, model results imply that antioxidants would need to be applied judiciously at the correct intervals (a sustained, moderate level) to have a noticeable effect on HIF1␣ levels either in the cancer or ischemic-reperfusion microenvironment. The optimal concentration would be dictated by the hypoxic microenvironment, and the model suggests noticeably higher doses would be needed to avoid reperfusion injury than those needed to prevent cancer cell proliferation or reduce ischemic damage alone.
